Cervical cancer cells induce apoptosis in TCD4+ lymphocytes through the secretion of TGF-β. (Q39239127)

10 September 2017

title

Cervical cancer cells induce apoptosis in TCD4+ lymphocytes through the secretion of TGF-β. (English)

1 reference

10 September 2017

Hugo López-Muñoz

1

1 reference

10 September 2017

Ma Luisa Escobar-Sánchez

2

1 reference

10 September 2017

Rebeca López-Marure

3

1 reference

10 September 2017

Ricardo Lascurain-Ledesma

4

1 reference

10 September 2017

Edgar Zenteno

5

1 reference

10 September 2017

José M V Hernández-Vazquez

6

1 reference

10 September 2017

Benny Weiss-Steider

7

1 reference

10 September 2017

Luis Sánchez-Sánchez

8

1 reference

10 September 2017

publication date

23 November 2012

1 reference

Archives of Gynecology and Obstetrics

10 September 2017

published in

1 reference

10 September 2017

volume

287

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

755-763

1 reference

Cytokine regulation networks in the cancer microenvironment

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

The dynamic roles of TGF-β in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Current concepts of tumor-infiltrating lymphocytes in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Concentration of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1) in the serum of patients with cervical cancer: prediction of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Transforming growth factor (TGF)-β expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

TGF beta inhibition for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3+ T lymphocytes in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-012-2621-Y

10.1007/S00404-012-2621-Y

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference